Avant Brands Inc - Asset Resilience Ratio
Avant Brands Inc (AVNT) has an Asset Resilience Ratio of 2.93% as of September 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read AVNT total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2018–2024)
This chart shows how Avant Brands Inc's Asset Resilience Ratio has changed over time. See Avant Brands Inc (AVNT) shareholders funds for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Avant Brands Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see AVNT market cap.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$1.74 Million | 2.93% |
| Short-term Investments | CA$0.00 | 0% |
| Total Liquid Assets | CA$1.74 Million | 2.93% |
Asset Resilience Insights
- Limited Liquidity: Avant Brands Inc maintains only 2.93% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Avant Brands Inc Industry Peers by Asset Resilience Ratio
Compare Avant Brands Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Daihan Pharmaceutical Co.Ltd
KQ:023910 |
Drug Manufacturers - Specialty & Generic | 11.95% |
|
Aurobindo Pharma Limited
NSE:AUROPHARMA |
Drug Manufacturers - Specialty & Generic | 16.92% |
|
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
SHE:000999 |
Drug Manufacturers - Specialty & Generic | 5.22% |
|
Ningbo Menovo Pharm Co Ltd
SHG:603538 |
Drug Manufacturers - Specialty & Generic | 2.69% |
|
Zhejiang Xianju Pharmaceutical Co Ltd
SHE:002332 |
Drug Manufacturers - Specialty & Generic | 6.02% |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365 |
Drug Manufacturers - Specialty & Generic | 30.38% |
|
Hainan Honz Pharmaceutical Co
SHE:300086 |
Drug Manufacturers - Specialty & Generic | 0.27% |
|
Guangdong Lifestrong Pharmacy Co. Ltd.
SHE:301111 |
Drug Manufacturers - Specialty & Generic | 7.85% |
Annual Asset Resilience Ratio for Avant Brands Inc (2018–2024)
The table below shows the annual Asset Resilience Ratio data for Avant Brands Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 2.93% | CA$1.74 Million ≈ $1.26 Million |
CA$59.47 Million ≈ $43.02 Million |
+1.96pp |
| 2023-12-31 | 0.96% | CA$794.00K ≈ $574.37K |
CA$82.55 Million ≈ $59.72 Million |
-9.15pp |
| 2022-12-31 | 10.11% | CA$6.78 Million ≈ $4.90 Million |
CA$67.03 Million ≈ $48.49 Million |
-18.54pp |
| 2021-12-31 | 28.65% | CA$14.49 Million ≈ $10.48 Million |
CA$50.57 Million ≈ $36.58 Million |
+27.12pp |
| 2020-12-31 | 1.53% | CA$625.00K ≈ $452.12K |
CA$40.80 Million ≈ $29.51 Million |
-4.00pp |
| 2019-12-31 | 5.53% | CA$2.51 Million ≈ $1.81 Million |
CA$45.31 Million ≈ $32.78 Million |
+3.26pp |
| 2018-12-31 | 2.28% | CA$917.60K ≈ $663.78K |
CA$40.32 Million ≈ $29.16 Million |
-- |
About Avant Brands Inc
Avant Brands Inc. cultivates, produces, markets, and sells cannabis products in Canada. The company offers recreational cannabis products under the BLK MKT, Tenzo, Cognoscente, Treehugger, Pristine, and Flowr brands. It also provides medical cannabis products under the GreenTec brand. The company distributes cannabis through medical and recreational sales channels, as well as an e-commerce websit… Read more